BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 16416686)

  • 21. Knowledge and awareness of cervical cancer and screening among Malaysian women who have never had a Pap smear: a qualitative study.
    Wong LP; Wong YL; Low WY; Khoo EM; Shuib R
    Singapore Med J; 2009 Jan; 50(1):49-53. PubMed ID: 19224084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlates of intent to seek unnecessary pap tests among elderly women.
    Zhang Y; Borders TF; Rohrer JE
    Womens Health Issues; 2007; 17(6):351-9. PubMed ID: 17936642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid.
    Dhaubhadel P; Vaidya A; Choudhary P
    JNMA J Nepal Med Assoc; 2008; 47(170):71-6. PubMed ID: 18709035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
    Lonky NM; Hunter MI; Sadeghi M; Edwards G; Bajamundi K; Monk BJ
    J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. English proficiency and physicians' recommendation of Pap smears among Hispanics.
    De Alba I; Sweningson JM
    Cancer Detect Prev; 2006; 30(3):292-6. PubMed ID: 16844320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pap smear screening and invasive cervical cancer.
    Brown RK; Barker WH
    J Fam Pract; 1982 Nov; 15(5):875-9. PubMed ID: 7130915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathways to diagnosis of cervical cancer: screening history, delay in follow up, and smear reading.
    Priest P; Sadler L; Peters J; Crengle S; Bethwaite P; Medley G; Jackson R
    BJOG; 2007 Apr; 114(4):398-407. PubMed ID: 17166215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of cervical cancer screening programme in the Harare City Health Department, Zimbabwe.
    Moyo IM; Koni NP; Makunike B; Hipshman J; Makaure HK; Gumbo N
    Cent Afr J Med; 1997 Aug; 43(8):223-5. PubMed ID: 9431759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in predictors of cervical and breast cancer screening by screening need in uninsured Latino women.
    Buki LP; Jamison J; Anderson CJ; Cuadra AM
    Cancer; 2007 Oct; 110(7):1578-85. PubMed ID: 17696119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The roles of citizenship status, acculturation, and health insurance in breast and cervical cancer screening among immigrant women.
    Echeverria SE; Carrasquillo O
    Med Care; 2006 Aug; 44(8):788-92. PubMed ID: 16862042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cervical cancer: how often--and why--to screen older women.
    Mandelblatt JS; Phillips RN
    Geriatrics; 1996 Jun; 51(6):45-8; quiz 49. PubMed ID: 8647475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
    van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience.
    Sepúlveda C; Prado R
    Cancer Detect Prev; 2005; 29(5):405-11. PubMed ID: 16188399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cervical cancer screening and associated treatment costs in France].
    Bergeron C; Breugelmans JG; Bouée S; Lorans C; Bénard S; Rémy V
    Gynecol Obstet Fertil; 2006 Nov; 34(11):1036-42. PubMed ID: 17070085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why women still die from cervical cancer.
    Masood S
    J Fla Med Assoc; 1997; 84(6):379-83. PubMed ID: 9379163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A project to improve the screening rate of pap smear for cervical cancer].
    Lin HH; Chen SH; Jeng SY; Chen HM
    Hu Li Za Zhi; 2007 Feb; 54(1):62-9. PubMed ID: 17340549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Educational level and cervical cancer screening programs in a Venezuelan urban area.
    Núñez-Troconis J; Velásquez J; Mindiola R; Munroe D
    Invest Clin; 2008 Sep; 49(3):331-9. PubMed ID: 18846774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Women at risk: papanicolaou smear screening in Florida.
    Vincent AL; Greene JN; Hoercherl S; McTague D
    J Fla Med Assoc; 1997; 84(5):302-7. PubMed ID: 9260433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in abnormal cancer screening results in the United States of America.
    Yabroff KR; Freedman A; Brown ML; Ballard-Barbash R; McNeel T; Taplin S
    J Med Screen; 2007; 14(2):67-72. PubMed ID: 17626704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profile of Pap smear cytology in the Western region of Saudi Arabia.
    Jamal A; Al-Maghrabi JA
    Saudi Med J; 2003 Nov; 24(11):1225-9. PubMed ID: 14647558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.